Introduction: The wholesale FOXO4 DRI peptide selectively induces apoptosis in senescent cells by disrupting FOXO4-p53 binding, offering secure, higher-purity products for growing old and most cancers analysis. Daily laboratory workflows frequently expose a persistent problem: the gradual and inefficient removal of senescent cells that impair tiss